BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21196635)

  • 1. Free water clearance: its behavior in chronic renal disease at different ages.
    Musso CG; Reynaldi J; Martinez B; Pierangelo A; Mombelli C; Vilas M; Algranati L
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):148-50. PubMed ID: 21196635
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of renal function in elderly patients.
    Fliser D
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):604-8. PubMed ID: 18941354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of chronic kidney disease in a Flemish primary care morbidity register.
    Van Pottelbergh G; Bartholomeeusen S; Buntinx F; Degryse J
    Age Ageing; 2012 Mar; 41(2):231-3. PubMed ID: 22139048
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of glomerular filtration rate and of albuminuria/proteinuria.
    Cirillo M
    J Nephrol; 2010; 23(2):125-32. PubMed ID: 20213606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albuminuria and cardiovascular risk: time for a new direction?
    Charytan DM
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1235-7. PubMed ID: 21597027
    [No Abstract]   [Full Text] [Related]  

  • 6. Reporting the eGFR and its implication for CKD diagnosis.
    Botev R; Mallié JP
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1606-7. PubMed ID: 18922981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the chronic kidney disease-epidemiology study equations for estimating glomerular filtration rate before and after nephrectomy.
    Lane BR; Demirjian S; Weight CJ; Larson BT; Poggio ED; Campbell SC
    J Urol; 2010 Mar; 183(3):896-901. PubMed ID: 20083272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological markers of renal dysfunction in essential arterial hypertension in African subjects].
    Djoumessi S; Nouedoui C; Youmbissi TJ; Essengue Behl GF
    Ann Biol Clin (Paris); 2000; 58(5):615-7. PubMed ID: 11022107
    [No Abstract]   [Full Text] [Related]  

  • 9. Cystatin C measurement and its practical use in patients with various renal diseases.
    Tian S; Kusano E; Ohara T; Tabei K; Itoh Y; Kawai T; Asano Y
    Clin Nephrol; 1997 Aug; 48(2):104-8. PubMed ID: 9285147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease.
    Lorenzen J; Krämer R; Kliem V; Bode-Boeger SM; Veldink H; Haller H; Fliser D; Kielstein JT
    Eur J Clin Invest; 2010 Apr; 40(4):294-300. PubMed ID: 20486990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glomerular filtration markers in pediatrics].
    Prévot A; Martini S; Guignard JP
    Rev Med Suisse Romande; 2002 Dec; 122(12):625-30. PubMed ID: 12611189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Ren Fail; 2008; 30(2):181-6. PubMed ID: 18300118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of GFR: a comparison of new and established equations.
    Cirillo M; Lombardi C; Luciano MG; Bilancio G; Anastasio P; De Santo NG
    Am J Kidney Dis; 2010 Oct; 56(4):802-4. PubMed ID: 20801570
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical practice guidelines for chronic kidney disease in adults: Part II. Glomerular filtration rate, proteinuria, and other markers.
    Johnson CA; Levey AS; Coresh J; Levin A; Lau J; Eknoyan G
    Am Fam Physician; 2004 Sep; 70(6):1091-7. PubMed ID: 15456118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional renal reserve capacity in different stages of chronic kidney disease.
    Barai S; Gambhir S; Prasad N; Sharma RK; Ora M
    Nephrology (Carlton); 2010 Apr; 15(3):350-3. PubMed ID: 20470306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a new plasma cystatin C-based formula and the Modification of Diet in Renal Disease creatinine-based formula for determination of glomerular filtration rate.
    Sterner G; Björk J; Carlson J; Grubb A; Nyman U
    Scand J Urol Nephrol; 2009; 43(3):242-9. PubMed ID: 19291590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of advanced age and renal dysfunction on the single- and repeated-dose pharmacokinetics of modified-release flupirtine.
    de Mey C; Gatchev E; Deliyska B; Terhaag B
    Int J Clin Pharmacol Ther; 2015 Mar; 53(3):247-55. PubMed ID: 25613539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What's in a name, AKI?
    Davis CL
    Liver Transpl; 2009 May; 15(5):455-6. PubMed ID: 19399738
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of aminoglycoside clearance using the modification of diet in renal disease equation versus the Cockcroft-Gault equation as a marker of glomerular filtration rate.
    Ryzner KL
    Ann Pharmacother; 2010 Jun; 44(6):1030-7. PubMed ID: 20424182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance.
    Karstila K; Harmoinen AP; Lehtimäki TJ; Korpela MM; Mustonen JT; Saha HH
    Nephron Clin Pract; 2008; 108(4):c284-90. PubMed ID: 18434750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.